RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage

Zubaidah M. Ramdzan, Charles Vadnais, Ranjana Pal, Guillaume Vandal, Chantal Cadieux, Lam Leduy, Sayeh Davoudi, Laura Hulea, Lu Yao, Anthony Karnezis, Marilène Paquet, David Dankort, Alain Nepveu

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The Cut homeobox 1 (CUX1) gene is a target of loss-of-heterozygosity in many cancers, yet elevated CUX1 expression is frequently observed and is associated with shorter disease-free survival. The dual role of CUX1 in cancer is illustrated by the fact that most cell lines with CUX1 LOH display amplification of the remaining allele, suggesting that decreased CUX1 expression facilitates tumor development while increased CUX1 expression is needed in tumorigenic cells. Indeed, CUX1 was found in a genome-wide RNAi screen to identify synthetic lethal interactions with oncogenic RAS. Here we show that CUX1 functions in base excision repair as an ancillary factor for the 8-oxoG-DNA glycosylase, OGG1. Single cell gel electrophoresis (comet assay) reveals that Cux1+/- MEFs are haploinsufficient for the repair of oxidative DNA damage, whereas elevated CUX1 levels accelerate DNA repair. In vitro base excision repair assays with purified components demonstrate that CUX1 directly stimulates OGG1's enzymatic activity. Elevated reactive oxygen species (ROS) levels in cells with sustained RAS pathway activation can cause cellular senescence. We show that elevated expression of either CUX1 or OGG1 prevents RAS-induced senescence in primary cells, and that CUX1 knockdown is synthetic lethal with oncogenic RAS in human cancer cells. Elevated CUX1 expression in a transgenic mouse model enables the emergence of mammary tumors with spontaneous activating Kras mutations. We confirmed cooperation between KrasG12V and CUX1 in a lung tumor model. Cancer cells can overcome the antiproliferative effects of excessive DNA damage by inactivating a DNA damage response pathway such as ATM or p53 signaling. Our findings reveal an alternate mechanism to allow sustained proliferation in RAS-transformed cells through increased DNA base excision repair capability. The heightened dependency of RAS-transformed cells on base excision repair may provide a therapeutic window that could be exploited with drugs that specifically target this pathway.

Original languageEnglish (US)
Article numbere1001807
JournalPLoS Biology
Volume12
Issue number3
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Homeobox Genes
DNA damage
DNA Damage
DNA repair
Repair
DNA
Tumors
Cells
cells
DNA Repair
lethal genes
neoplasms
Assays
Genes
DNA Glycosylases
glycosylases
mammary neoplasms (animal)
Automatic teller machines
Neoplasms
assays

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Ramdzan, Z. M., Vadnais, C., Pal, R., Vandal, G., Cadieux, C., Leduy, L., ... Nepveu, A. (2014). RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. PLoS Biology, 12(3), [e1001807]. https://doi.org/10.1371/journal.pbio.1001807

RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. / Ramdzan, Zubaidah M.; Vadnais, Charles; Pal, Ranjana; Vandal, Guillaume; Cadieux, Chantal; Leduy, Lam; Davoudi, Sayeh; Hulea, Laura; Yao, Lu; Karnezis, Anthony; Paquet, Marilène; Dankort, David; Nepveu, Alain.

In: PLoS Biology, Vol. 12, No. 3, e1001807, 01.01.2014.

Research output: Contribution to journalArticle

Ramdzan, ZM, Vadnais, C, Pal, R, Vandal, G, Cadieux, C, Leduy, L, Davoudi, S, Hulea, L, Yao, L, Karnezis, A, Paquet, M, Dankort, D & Nepveu, A 2014, 'RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage', PLoS Biology, vol. 12, no. 3, e1001807. https://doi.org/10.1371/journal.pbio.1001807
Ramdzan ZM, Vadnais C, Pal R, Vandal G, Cadieux C, Leduy L et al. RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. PLoS Biology. 2014 Jan 1;12(3). e1001807. https://doi.org/10.1371/journal.pbio.1001807
Ramdzan, Zubaidah M. ; Vadnais, Charles ; Pal, Ranjana ; Vandal, Guillaume ; Cadieux, Chantal ; Leduy, Lam ; Davoudi, Sayeh ; Hulea, Laura ; Yao, Lu ; Karnezis, Anthony ; Paquet, Marilène ; Dankort, David ; Nepveu, Alain. / RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage. In: PLoS Biology. 2014 ; Vol. 12, No. 3.
@article{19152422ef2f458d9e94e2efa74535b2,
title = "RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage",
abstract = "The Cut homeobox 1 (CUX1) gene is a target of loss-of-heterozygosity in many cancers, yet elevated CUX1 expression is frequently observed and is associated with shorter disease-free survival. The dual role of CUX1 in cancer is illustrated by the fact that most cell lines with CUX1 LOH display amplification of the remaining allele, suggesting that decreased CUX1 expression facilitates tumor development while increased CUX1 expression is needed in tumorigenic cells. Indeed, CUX1 was found in a genome-wide RNAi screen to identify synthetic lethal interactions with oncogenic RAS. Here we show that CUX1 functions in base excision repair as an ancillary factor for the 8-oxoG-DNA glycosylase, OGG1. Single cell gel electrophoresis (comet assay) reveals that Cux1+/- MEFs are haploinsufficient for the repair of oxidative DNA damage, whereas elevated CUX1 levels accelerate DNA repair. In vitro base excision repair assays with purified components demonstrate that CUX1 directly stimulates OGG1's enzymatic activity. Elevated reactive oxygen species (ROS) levels in cells with sustained RAS pathway activation can cause cellular senescence. We show that elevated expression of either CUX1 or OGG1 prevents RAS-induced senescence in primary cells, and that CUX1 knockdown is synthetic lethal with oncogenic RAS in human cancer cells. Elevated CUX1 expression in a transgenic mouse model enables the emergence of mammary tumors with spontaneous activating Kras mutations. We confirmed cooperation between KrasG12V and CUX1 in a lung tumor model. Cancer cells can overcome the antiproliferative effects of excessive DNA damage by inactivating a DNA damage response pathway such as ATM or p53 signaling. Our findings reveal an alternate mechanism to allow sustained proliferation in RAS-transformed cells through increased DNA base excision repair capability. The heightened dependency of RAS-transformed cells on base excision repair may provide a therapeutic window that could be exploited with drugs that specifically target this pathway.",
author = "Ramdzan, {Zubaidah M.} and Charles Vadnais and Ranjana Pal and Guillaume Vandal and Chantal Cadieux and Lam Leduy and Sayeh Davoudi and Laura Hulea and Lu Yao and Anthony Karnezis and Maril{\`e}ne Paquet and David Dankort and Alain Nepveu",
year = "2014",
month = "1",
day = "1",
doi = "10.1371/journal.pbio.1001807",
language = "English (US)",
volume = "12",
journal = "PLoS Biology",
issn = "1544-9173",
publisher = "Public Library of Science",
number = "3",

}

TY - JOUR

T1 - RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage

AU - Ramdzan, Zubaidah M.

AU - Vadnais, Charles

AU - Pal, Ranjana

AU - Vandal, Guillaume

AU - Cadieux, Chantal

AU - Leduy, Lam

AU - Davoudi, Sayeh

AU - Hulea, Laura

AU - Yao, Lu

AU - Karnezis, Anthony

AU - Paquet, Marilène

AU - Dankort, David

AU - Nepveu, Alain

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The Cut homeobox 1 (CUX1) gene is a target of loss-of-heterozygosity in many cancers, yet elevated CUX1 expression is frequently observed and is associated with shorter disease-free survival. The dual role of CUX1 in cancer is illustrated by the fact that most cell lines with CUX1 LOH display amplification of the remaining allele, suggesting that decreased CUX1 expression facilitates tumor development while increased CUX1 expression is needed in tumorigenic cells. Indeed, CUX1 was found in a genome-wide RNAi screen to identify synthetic lethal interactions with oncogenic RAS. Here we show that CUX1 functions in base excision repair as an ancillary factor for the 8-oxoG-DNA glycosylase, OGG1. Single cell gel electrophoresis (comet assay) reveals that Cux1+/- MEFs are haploinsufficient for the repair of oxidative DNA damage, whereas elevated CUX1 levels accelerate DNA repair. In vitro base excision repair assays with purified components demonstrate that CUX1 directly stimulates OGG1's enzymatic activity. Elevated reactive oxygen species (ROS) levels in cells with sustained RAS pathway activation can cause cellular senescence. We show that elevated expression of either CUX1 or OGG1 prevents RAS-induced senescence in primary cells, and that CUX1 knockdown is synthetic lethal with oncogenic RAS in human cancer cells. Elevated CUX1 expression in a transgenic mouse model enables the emergence of mammary tumors with spontaneous activating Kras mutations. We confirmed cooperation between KrasG12V and CUX1 in a lung tumor model. Cancer cells can overcome the antiproliferative effects of excessive DNA damage by inactivating a DNA damage response pathway such as ATM or p53 signaling. Our findings reveal an alternate mechanism to allow sustained proliferation in RAS-transformed cells through increased DNA base excision repair capability. The heightened dependency of RAS-transformed cells on base excision repair may provide a therapeutic window that could be exploited with drugs that specifically target this pathway.

AB - The Cut homeobox 1 (CUX1) gene is a target of loss-of-heterozygosity in many cancers, yet elevated CUX1 expression is frequently observed and is associated with shorter disease-free survival. The dual role of CUX1 in cancer is illustrated by the fact that most cell lines with CUX1 LOH display amplification of the remaining allele, suggesting that decreased CUX1 expression facilitates tumor development while increased CUX1 expression is needed in tumorigenic cells. Indeed, CUX1 was found in a genome-wide RNAi screen to identify synthetic lethal interactions with oncogenic RAS. Here we show that CUX1 functions in base excision repair as an ancillary factor for the 8-oxoG-DNA glycosylase, OGG1. Single cell gel electrophoresis (comet assay) reveals that Cux1+/- MEFs are haploinsufficient for the repair of oxidative DNA damage, whereas elevated CUX1 levels accelerate DNA repair. In vitro base excision repair assays with purified components demonstrate that CUX1 directly stimulates OGG1's enzymatic activity. Elevated reactive oxygen species (ROS) levels in cells with sustained RAS pathway activation can cause cellular senescence. We show that elevated expression of either CUX1 or OGG1 prevents RAS-induced senescence in primary cells, and that CUX1 knockdown is synthetic lethal with oncogenic RAS in human cancer cells. Elevated CUX1 expression in a transgenic mouse model enables the emergence of mammary tumors with spontaneous activating Kras mutations. We confirmed cooperation between KrasG12V and CUX1 in a lung tumor model. Cancer cells can overcome the antiproliferative effects of excessive DNA damage by inactivating a DNA damage response pathway such as ATM or p53 signaling. Our findings reveal an alternate mechanism to allow sustained proliferation in RAS-transformed cells through increased DNA base excision repair capability. The heightened dependency of RAS-transformed cells on base excision repair may provide a therapeutic window that could be exploited with drugs that specifically target this pathway.

UR - http://www.scopus.com/inward/record.url?scp=84898983512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898983512&partnerID=8YFLogxK

U2 - 10.1371/journal.pbio.1001807

DO - 10.1371/journal.pbio.1001807

M3 - Article

C2 - 24618719

AN - SCOPUS:84898983512

VL - 12

JO - PLoS Biology

JF - PLoS Biology

SN - 1544-9173

IS - 3

M1 - e1001807

ER -